GEA Announces Figures for the Third Quarter

03.11.2016

GEA s order intake in the third quarter of 2016 was EUR 1,084 million.

The development was impacted by delays in the awarding of projects, above all in the dairy processing sector, a decline in orders from the oil and gas industry, and by the ongoing challenging economic environment in the dairy farming customer industry. Due to weaker growth in the Business Area Solutions, third-quarter revenue fell to EUR 1,101 million.

Operating EBITDA in the third quarter was EUR 113 million. The decline compared with the prior year s figure is largely explained by cost overruns in a few major projects and by the impact of reduced capacity utilization arising from the contraction in revenue.

"Although business remains solid in many of our customer industries, the group has experienced negative financial performance in certain areas during the third quarter, which cannot be fully compensated towards the end of the financial year. As a result, we have adjusted our forecast for the 2016 financial year a few days ago," said Jürg Oleas, Chairman of the Executive Board of GEA in his appraisal of the present situation.

More articles on this topic

ACHEMA 2024: Call for Papers for the ACHEMA Congress Opens

ACHEMA 2024: Call for Papers for the ACHEMA Congress Opens

22.05.2023 -

It’s just over a year away: ACHEMA 2024, the World Forum for Chemical Engineering, Process Engineering and Biotechnology and the world’s leading show for the process industries, will take place in Frankfurt am Main, Germany, from 10 to 14 June 2024. Now the Call for Papers for the ACHEMA Congress opens. Submissions are possible until 6 October 2023.

Read more
Peroxidic-Crosslinked Fluoroelastomer from Freudenberg Meets the Latest Regulatory Requirements of the Process Industry

Peroxidic-Crosslinked Fluoroelastomer from Freudenberg Meets the Latest Regulatory Requirements of the Process Industry

26.04.2023 -

Freudenberg Sealing Technologies’ peroxidic-crosslinked fluoroelastomer material 75 FKM 239961 now also has received pharma-specific approval according to USP Chapter 87. The result of the in vitro conformity test confirms that the material has no toxic effects on cell cultures. With this advancement, bisphenol crosslinked FKM materials can be replaced in the food industry.

Read more
最终报告ACHEMA 2022

最终报告ACHEMA 2022

08.09.2022 -

At ACHEMA 2022, the world’s leading trade show for the process industry, over 2,200 exhibitors from more than 50 countries showcased the latest equipment and innovative processes for the chemical, pharmaceutical and food industries at the Frankfurt fairgrounds from 22 to 26 August.

Read more